Psychological stress and melanoma: Are we meeting our patients' psychological needs?

Clinics in Dermatology

Volumn 31, Issue 1, 2013, Pages 41-46

  Kasparian, Nadine Angele ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANXIETY DISORDER; ATTITUDE TO ILLNESS; BEHAVIOR THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; DEPRESSION; DISEASE ASSOCIATION; DISTRESS SYNDROME; EDUCATIONAL STATUS; EMOTIONAL STRESS; EMPLOYMENT STATUS; HEALTH CARE NEED; HUMAN; MELANOMA; MENTAL STRESS; MOOD DISORDER; NOTE; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PATIENT SAFETY; PREVALENCE; PRIORITY JOURNAL; PSYCHODYNAMICS; PSYCHOTHERAPY; QUALITY OF LIFE; SEX DIFFERENCE; SKIN EXAMINATION; SOCIAL SUPPORT; SURVIVAL TIME; THERAPY DELAY;

HUMANS; MELANOMA; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRESS, PSYCHOLOGICAL;

EID: 84871101954     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.11.005     Document Type: Note

References (69)

1. Smith N., Fuhrmann T., Tausk F. Psychoneuro-oncology: its time has arrived. Arch Dermatol 2009, 145:1439-1442.
2. Thomas L. Foreword to the Handbook of Psycho-Oncology 1989, Oxford University Press, New York. J. Holland, J. Rowland (Eds.).
3. Folkman S., Guer S. Promoting psychological well-being in the face of serious illness: when theory, research and practice inform each other. Psycho-Oncol 2000, 9:11-19.
4. Hodgkinson K., Gilchrist J. Psychosocial care of cancer patients: a health professional's guide to what to say and do 2008, Ausmed Publications, Melbourne.
5. Boyle D.A. Psychological adjustment to the melanoma experience. Sem Oncol Nurs 2003, 19:70-77.
6. Spiegel D. Cancer and depression. Br J Psychiatry 1996, 30:109-116.
7. DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101-2107.
8. Butow P., Coates A., Dunn S. Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 1999, 17:2256-2263.
9. Manning W., Wells K. The effect of psychological distress and psychological well-being on use of medical services. Med Care 1992, 30:541-553.
10. Simon G., Ormel J., Von Korff M., et al. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995, 152:352-357.
11. Kittler H., Weitzdorfer R., Pehamberger H., et al. Compliance with follow-up and prognosis among patients with thin melanomas. Eur J Cancer 1504, 37:1504-1509.
12. Kasparian N., McLoone J., Butow P. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 2009, 145:1415-1427.
13. Zabora J., Brintzenhofeszoc K., Curbow B., et al. The prevalence of psychological distress by cancer site. Psychooncology 2001, 10:19-28.
14. Gibertini M., Reintgen D.S., Baile W.F. Psychosocial aspects of melanoma. Ann Plast Surg 1992, 28:17-21.
15. Trask P.C., Paterson A.G., Hayasaka S., et al. Psychosocial characteristics of individuals with non-stage IV melanoma. J Clin Oncol 2001, 19:2844-2850.
16. Kelly B., Raphael B., Smithers M., et al. Psychological responses to malignant melanoma. An investigation of traumatic stress reactions to life-threatening illness. Gen Hosp Psychiatry 1995, 17:126-134.
17. Brandberg Y., Bolund C., Sigurdardottir V., et al. Anxiety and depressive symptoms at different stages of malignant melanoma. Psychooncology 1992, 1:71-78.
18. Al-Shakhli H., Harcourt D., Kenealy J. Psychological distress surrounding diagnosis of malignant and nonmalignant skin lesions at a pigmented lesion clinic. J Plast Reconstr Aesthet Surg 2006, 59:479-486.
19. Hamama-Raz Y., Solomon Z., Schachter J., et al. Objective and subjective stressors and the psychological adjustment of melanoma survivors. Psychooncology 2007, 16:287-294.
20. Kasparian N., Meiser B., Butow P., et al. Predictors of psychological distress among individuals with a strong family history of malignant melanoma. Clin Genet 2008, 73:121-131.
21. Cornish D., Holterhues C., van de Poll-Franse L.V., et al. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol 2009, 20:vi51-vi58.
22. Sollner W., Zingg-Schir M., Rumpold G., et al. Need for supportive counselling-the professionals' versus the patients' perspective: a survey in a representative sample of 236 melanoma patients. Psychother Psychosom 1998, 67:94-104.
23. Cassileth B.R., Lusk E.J., Tenaglia A.N. Patients' perceptions of the cosmetic impact of melanoma resection. Plast Reconstr Surg 1983, 71:73-75.
24. Newton-Bishop J.A., Nolan C., Turner F., et al. A quality-of-life study in high-risk (thickness > = or 2 mm. cutaneous melanoma patients in a randomized trial of 1-cm versus 3-cm surgical excision margins. J Investig Dermatol Symp Proc 2004, 9:152-159.
25. Ko C.Y., Maggard M., Livingston E.H., et al. Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessment. J Surg Res 2003, 114:1-5.
26. Brandberg Y., Mansson-Brahme E., Ringborg U., et al. Psychological reactions in patients with malignant melanoma. Eur J Cancer 1995, 31A:157-162.
27. Baughan C.A., Hall V.L., Leppard B.J., et al. Follow-up in stage I cutaneous malignant melanoma: An audit. Clin Oncol 1993, 5:174-180.
28. Francken A.B., Bastiaannet E., Hoekstra H.J., et al. Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol 2005, 6:608-621.
29. Foot G., Sanson-Fisher R. Measuring unmet needs of people living with cancer. Cancer Forum 1995, 19:131-135.
30. Fallowfield L., Hall A., Maguire P., et al. Psychological effects of being offered choice of surgery for breast cancer. Br Med J 1994, 309:448.
31. Thorne S., Bultz B., Baile W., et al. Is there a cost to poor communication in cancer care? A critical review of the literature. Psychooncol 2005, 14:875-884.
32. Brandberg Y., Bergenmar M., Bolund C., et al. Information to patients with malignant melanoma: a randomized group study. Patient Educ Couns 1994, 23:97-105.
33. Bonevski B., Sanson-Fisher R., Hersey P., et al. Assessing the perceived needs of patients attending an outpatient melanoma clinic. J Psychosoc Oncol 1999, 17:101-118.
34. McLoone J, Watts K, Menzies S, et al. When the risks are high: psychological experiences and unmet needs of melanoma survivors at high risk of developing new primary disease. Psychooncol. Qualitative Health Research. In Press (Accepted 8 September 2011).
35. Schofield P.E., Butow P.N., Thompson J.F., et al. Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol 2003, 14:48-56.
36. Bergenmar M., Nilsson B., Hansson J., et al. Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma. Acta Oncol 2004, 43:161-168.
37. Canada A., Fawzy N., Fawzy F. Personality and disease outcome in malignant melanoma. J Psychosom Res 2005, 58:19-27.
38. Cassileth B., Walsh W., Lusk E. Psychosocial correlates of cancer survival: A subsequent report 3 to 8 years after cancer diagnosis. J Clin Oncol 1988, 6:1753-1759.
39. Fawzy F., Fawzy N., Hyun C., et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993, 50:681-689.
40. Brown J., Brown R., Miller R., et al. Coping with metastatic melanoma: the last year of life. Psychooncology 2000, 9:283-292.
41. Rogentine G.N., van Kammen D.P., Fox B.H., et al. Psychological factors in the prognosis of malignant melanoma: a prospective study. Psychosom Med 1979, 41:647-655.
42. Lehto U.S., Ojanen M., Dyba T., et al. Baseline psychosocial predictors of survival in localized melanoma. J Psychosom Res 2007, 63:9-15.
43. Temoshok L. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response. Soc Sci Med 1985, 20:833-840.
44. Temoshok L., Heller B.W., Sagebiel R.W., et al. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J Psychosom Res 1985, 29:139-153.
45. Fawzy F., Fawzy N., Arndt L., et al. Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 1995, 52:100-113.
46. Moyer A., Sohl S.J., Knapp-Oliver S.K., et al. Characteristics and methodological quality of 25 years of research investigating psychosocial interventions for cancer patients. Cancer Treat Rev 2009, 35:475-484.
47. Webel A.R., Okonsky J., Trompeta J., et al. A systematic review of the effectiveness of peer-based interventions on health-related behaviors in adults. Am J Public Health 2010, 100:247-253.
48. Andersen B.L. Psychological interventions for cancer patients to enhance the quality of life. J Consult Clin Psychol 1992, 60:235-238.
49. Trijsburg R.W., Knippenberg F.C., Rijpma S.E. Effects of psychological treatmenton cancer patients: a critical review. Psychosom Med 1992, 54:489-517.
50. Meyer T.J., Mark M.M. Effects of psychosocial interventions with adult cancer patients: meta-analysis of randomized experiments. Health-Psychology 1995, 14:101-108.
51. Orringer J.S., Fendrick A.M., Trask P.C., et al. The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: a randomized, prospective clinical trial. J Am Acad Dermatol 2005, 53:224-229.
52. Brandberg Y., Bergenmar M., Michelson H., et al. Six-month follow-up of effects of an information programme for patients with malignant melanoma. Patient Educ Couns 1996, 28:201-208.
53. Robinson J., Turrisi R. Skills training to learn discrimination of ABCDE criteria by those at risk of developing melanoma. Arch Dermatol 2006, 142:447-452.
54. Robinson J., Turrisi R., Stapleton J. Efficacy of a partner assistance intervention designed to increase skin self-examination performance. Arch Dermatol 2007, 143:37-41.
55. Rudy R., Rosenfeld L., Galassi J., et al. Participants' perceptions of a peer-helper, telephone-based social support intervention for melanoma patients. Health Communication 2001, 13:285-305.
56. MacCormack T., Simonian J, Lim J., et al. 'Someone who cares': A qualitative investigation of cancer patients' experiences of psychotherapy. Psychooncology 2001, 10:52-65.
57. Fawzy F.I., Kemeny M.E., Fawzy N.W., et al. A structured psychiatric intervention for cancer patients: I. Changes over time and methods of coping in affect of disturbance. Arch Gen Psychiatry 1990, 47:720-725.
58. Fawzy F.I., Kemeny M.E., Fawzy N.W., et al. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 1990, 47:729-735.
59. Boesen E.H., Ross L., Frederiksen K., et al. Psychoeducational intervention for patients with cutaneous malignant melanoma: A replication study. J Clin Oncol 2005, 23:1270-1277.
60. Fawzy N.W. A psychoeducational nursing intervention to enhance coping and affective state in newly diagnosed malignant melanoma patients. Cancer Nurs 1995, 18:427-438.
61. Bares C.B., Trask P.C., Schwartz S.M. An exercise in cost-effectiveness analysis: treating emotional distress in melanoma patients. J Clin Psychol Med Settings 2002, 9:193-200.
62. Trask P.C., Paterson A.G., Griffith K.A., et al. Cognitive-behavioral intervention for distress in patients with melanoma: comparison with standard medical care and impact on quality of life. Cancer 2003, 98:854-864.
63. Psychosocial clinical practice guidelines: providing information, support, and counselling for women with breast cancer 2000, National Health & Medical Research Council (NHMRC) National Breast Cancer Centre Psychosocial Working Group, Commonwealth of Australia, Canberra ACT.
64. Australian Cancer Network Clinical practice guidelines for the management of melanoma in Australia and New Zealand 2008, National Health and Medical Research Council, Canberra.
65. 10-point plan for more comprehensive cancer care. CA Cancer J Clin 2008, 58:67-68. Institute of Medicine.
66. Schofield P., Carey M., Bonevski B., et al. Barriers to the provision of evidence-based psychosocial care in oncology. Psychooncology 2006, 15:863-872.
67. Lenfant C. Clinical research to clinical practice: lost in translation?. N Engl J Med 2003, 349:868-874.
68. Schwartz K., Vilquin J. Building the translational highway: toward new partnerships between academia and the private sector. Nat Med 2003, 9:493-495.
69. Holland J.C., Passik S., Kash K.M., et al. The role of religious and spiritual beliefs in coping with malignant melanoma. Psychooncology 1999, 8:14-26.